Form 8-K · Current report
Aflac 8-K, filed Nov 4, 2026
- Filed
- CIK
- 0000004977
- Accession no.
- 0001628280-26-070181
Summary
Aflac reported third-quarter 2026 net earnings of $303 million, or $0.61 per diluted share, down from $1.6 billion a year earlier, mainly on $1.1 billion of net investment losses tied to repositioning its investment portfolio, while adjusted earnings fell 8.5% to $1.2 billion and adjusted earnings per diluted share slipped 2.4% to $2.43. The company declared a fourth-quarter dividend of $0.61 per share, its 44th consecutive year of dividend increases, and said Aflac Japan ceded roughly ¥500 billion of cancer-insurance reserves to Aflac Re Bermuda.
Key points
- Adjusted earnings of $1.2 billion benefited from $453 million of reserve remeasurement gains.
- Aflac returned $1.1 billion to shareholders in the quarter: $804 million in share repurchases and $305 million in dividends.
- Aflac Japan's pretax adjusted earnings fell 15.2% in yen to ¥152.3 billion, with its pretax adjusted profit margin at 44.4% versus 52.2% a year earlier.
- The average yen/dollar rate of 158.49 was 6.8% weaker than a year earlier, reducing adjusted earnings per share by $0.03.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 2.02Results of Operations and Financial Condition
- 7.01Regulation FD Disclosure
- 9.01Financial Statements and Exhibits
From the filing
Item 2.02 Results of Operations and Financial Condition. On November 4, 2026, Aflac Incorporated (the "Company") issued a press release dated November 4, 2026 in which it reported the Company's 2026 third quarter financial results. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and incorporated by reference herein in its entirety. In addition, a copy of the Company's third quarter supplemental earnings materials is furnished as Exhibit 99.2 to this Current Report on Form 8-K and incorporated by reference herein in its entirety. Item 7.01 Regulation FD Disclosure. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.